Abstract:Background: Previous studies have mainly focused on the effects of individual fatty acids on depressive symptoms, while the combined effect of fatty acids on the risk of depressive symptoms has not yet been extensively reported. This study evaluate the associations between individual and multiple fatty acids with depressive symptoms in U.S. adults. Methods: Data sets were obtained from the National Health and Nutrition Examination Survey (NHANES) 2007-2018 cycles. Both males and females aged above 18 years with complete information about dietary fatty acids intake, depression symptoms, and covariates were included. Weighted linear regression models were conducted to evaluate the relationships between individual fatty acid intake and depressive symptoms, and restricted cubic spline (RCS) models were utilized to explore the corresponding dose-response relationships. Additionally, we implemented the weighted quantile sum (WQS) regression and quantile g-computation (QGC) models to estimate the mixed effects of 19 fatty acids and identify the predominant types. Results: After multivariable adjustments, an increase of one unit in Linoleic acid (LA), Alpha-Linolenic Acid (ALA), Arachidonic acid (AA), Docosapentaenoic acid(DPA), Docosahexaenoic acid(DHA), was associated with a decrease in depressive scores by -0.021 (95 % CI: -0.039,-0.003, p = 0.021),-0.028 (95 % CI: -0.045,-0.011, p = 0.002),-0.026 (95 % CI: -0.044,-0.008, p = 0.005), -0.026 (95 % CI: -0.042,-0.009, p = 0.003), and - 0.022 (95 % CI: -0.041,-0.003, p = 0.022), respectively. However, a per unit increase in Hexanoic acid and Octanoic acid was associated with an increase in depressive scores of 0.020 (95 % CI: 0.002,0.038, p = 0.029) and 0.026 (95 % CI: 0.004,0.048, p = 0.020), respectively. Meanwhile, significant dose-response relationships were supported by the RCS models. As for the mixed effects, both WQS and QGC models demonstrated that the mixture of polyunsaturated fatty acids (PUFAs) was inversely related to depressive symptoms, and ALA and DPA were the most critical contributors. DHA was negatively correlated with depressive symptoms in WQS analysis, but positively correlated with depressive symptoms in QGC analysis. Limitations: The cross-sectional design limits our ability to establish causality, and 24-hour dietary recall can lead to potential inaccuracies reflecting participants' true eating habits. Conclusion: Our study suggests that the single effects of each PUFA were inversely associated with depressive symptoms, except for octadecatetraenoic acid. Moreover, higher combined intake of dietary PUFAs is inversely associated with depressive symptoms in U.S. adults. Among the mixed effects of PUFAs, ALA and DPA may play predominant roles. However, DHA mixed with other fatty acids may have different effects on depressive symptoms, and further study is needed.

The Relationship between Fatty Acids and Different Depression-Related Brain Regions, and Their Potential Role as Biomarkers of Response to Antidepressants

Erythrocyte Membrane Fatty Acid Composition As a Potential Biomarker for Depression.

Focus on fatty acids in the neurometabolic pathophysiology of psychiatric disorders

Abnormal erythrocyte fatty acid composition in first-diagnosed, drug-naïve patients with depression

Relationships between fatty acids and psychophysiological parameters in depressive inpatients under experimentally induced stress

Food for mood: Relevance of nutritional Omega-3 fatty acids for depression and anxiety

Omega-3 Fatty Acids and Neuroinflammation in Depression: Targeting Damage-Associated Molecular Patterns and Neural Biomarkers

Sex differences in erythrocyte fatty acid composition of first-diagnosed, drug-naïve patients with major depressive disorders

Omega 3 polyunsaturated fatty acids and the treatment of depression

Association of serum fatty acid pattern with depression in U.S. adults: analysis of NHANES 2011–2012

The role of omega-3 polyunsaturated fatty acids eicosapentaenoic and docosahexaenoic acids in the treatment of major depression and Alzheimer's disease: Acting separately or synergistically?

Current Insights into the Use of Probiotics and Fatty Acids in Alleviating Depression

Lowered Ω3 Polyunsaturated Fatty Acids in Serum Phospholipids and Cholesteryl Esters of Depressed Patients

Omega-3 Polyunsaturated Fatty Acids in Depression

The role of unsaturated fatty acids in depression treatment - international clinical guidelines and recommendation of psychiatric associations

N-3 PUFA Supplementation Alleviates Anxiety Symptoms by Manipulating Erythrocyte Fatty Acid Levels in Depression.

Exploring the therapeutic potential of omega-3 fatty acids in depression

Fatty Acid Composition in Major Depression: Decreased Ω3 Fractions in Cholesteryl Esters and Increased C20:4ω6C20:5ω3 Ratio in Cholesteryl Esters and Phospholipids

Gut Microbiome-Linked Metabolites in the Pathobiology of Major Depression With or Without Anxiety-A Role for Bile Acids

Altered Neurometabolite Levels in the Brains of Patients with Depression: A Systematic Analysis of Magnetic Resonance Spectroscopy Studies

Associations of the intake of individual and multiple fatty acids with depressive symptoms among adults in NHANES 2007-2018